故事疗法延缓轻中度认知障碍老年人认知衰退的最佳证据总结

A summary of the best evidence for story therapy to delay cognitive decline in the elderly with mild to moderate cognitive impairment

目的评价总结故事疗法对延缓轻中度认知障碍老年人认知衰退的最佳证据。方法计算机检索UpToDate、SIGN、NZGG、Cochrane Library、医脉通、Embase、PubMed、中国知网(CNKI)、万方、维普数据库中关于故事疗法延缓轻中度认知障碍老年人认知衰退的所有指南、证据总结、最佳实践信息册、推荐实践、系统评价、专家意见、随机对照试验和准实验研究等。检索时限为2010年1月1日至2022年2月25日。采用相应的质量评价工具评价纳入的文献,总结有关故事疗法对延缓轻中度认知障碍老年人认知衰退的最佳证据。结果共纳入16篇文献,其中4篇系统评价、9篇随机对照试验、3篇准实验研究。经过评价,共总结了故事疗法类型、活动形式、场所选择、材料准备、干预时间、干预过程、注意事项、推广应用8个方面有关延缓轻中度认知障碍老年人认知衰退的33条最佳证据。结论本研究总结了目前关于故事疗法对延缓轻中度认知障碍老年人认知衰退的最佳证据,为轻中度认知障碍的非药物干预提供可操作性的参考意见。

Objective To evaluate and summarize the best evidence for the use of story therapy to delay cognitive decline in elderly with mild to moderate cognitive impairment.Methods UpToDate,SIGN,NZGG,Cochrane Library,Yimaitong,Embase,PubMed,CNKI,WanFang,and VIP databases were computer searched from January 1,2010 to February 25,2022 for all guidelines on story therapy for delaying cognitive decline in the elderly with mild to moderate cognitive impairment.Evidence summaries,best practice information books,recommended practices,systematic reviews,expert opinion,randomized controlled trials,and quasi-experimental studies were all included.Appropriate quality assessment tools were used to evaluate the included literature,and to summarize the best evidence on story therapy for delaying cognitive decline in older adults with mild to moderate cognitive impairment.Results A total of 16 articles were included:4 systematic reviews,9 randomized controlled trials,and 3 quasi-experimental studies.After evaluation,a total of 33 most important factors for delaying cognitive decline in the elderly with mild to moderate cognitive impairment were summarized,including story therapy type,activity form,venue selection,material preparation,intervention time,intervention process,precautions,and promotion and application.Conclusions This study summarizes the current best evidence on story therapy for delaying cognitive decline in the elderly with mild to moderate cognitive impairment,and provides practical reference for the practice of non-drug interventions for this group of patients.